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DyneinTransport of material and signals between extensive neuronal processes and the cell body is essential to
neuronal physiology and survival. Slowing of axonal transport has been shown to occur before the onset of
symptoms in amyotrophic lateral sclerosis (ALS). We have previously shown that several familial ALS-linked
copper–zinc superoxide dismutase (SOD1) mutants (A4V, G85R, and G93A) interacted and colocalized with
the retrograde dynein–dynactin motor complex in cultured cells and affected tissues of ALS mice. We also
found that the interaction between mutant SOD1 and the dynein motor played a critical role in the formation
of large inclusions containing mutant SOD1. In this study, we showed that, in contrast to the dynein
situation, mutant SOD1 did not interact with anterograde transport motors of the kinesin-1 family (KIF5A, B
and C). Using dynein and kinesin accumulation at the sciatic nerve ligation sites as a surrogate measurement
of axonal transport, we also showed that dynein mediated retrograde transport was slower in G93A than in
WT mice at an early presymptomatic stage. While no decrease in KIF5A-mediated anterograde transport was
detected, the slowing of anterograde transport of dynein heavy chain as a cargo was observed in the
presymptomatic G93A mice. The results from this study along with other recently published work support
that mutant SOD1 might only interact with and interfere with some kinesin members, which, in turn, could
result in the impairment of a selective subset of cargos. Although it remains to be further investigated how
mutant SOD1 affects different axonal transport motor proteins and various cargos, it is evident that mutant
SOD1 can induce defects in axonal transport, which, subsequently, contribute to the propagation of toxic
effects and ultimately motor neuron death in ALS.OD1, copper–zinc superoxide
red saline; GST, glutathione S-
IC, dynein intermediate chain;
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Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease
characterizedbymotorneurondeath.Mutations in theCu/Znsuperoxide
dismutase (SOD1) gene have been shown to cause 10% to 20% of familial
ALS (fALS) cases [1,2]. Mutations scattered in the SOD1 gene in a
seemingly random fashion can still speciﬁcally and exclusively lead to
ALS [3]. Evidence shows that ALS is not caused by the loss of the SOD1
activity, but by toxic properties gained by mutant SOD1 [4,5]. However,
the mechanism(s) of mutant SOD1-mediated toxicity remains unclear.
Transport of material and signals between extensive neuronal
processes and the cell body is essential to neuronal function and
survival. Members of the kinesin motor family transport cargos in theanterograde direction (toward the synapse), whereas cytoplasmic
dynein is themajormotor protein driving retrograde transport (toward
the cell body) in neurons. Many proteins needed in the axon and
synaptic terminal must be transported from the cell body where they
are synthesized. Both anterograde and retrograde transports are needed
to maintain homeostasis and correct localization of mitochondria in
neurons [6]. Furthermore, retrograde transport of signals induced by
neurotrophic factors is believed to be important for neuronal survival
[7,8]. Mutations in the axonal transport motor proteins can cause
neurological disorders. For instance, mutations in the anterograde
transport motor protein KIF5A can cause spastic paraplegia [9]. Several
mutations in the retrograde motor complex dynein–dynactin cause
motor neuron degeneration in humans and mice [10,11].
One characteristic of ALS disease is reduced axonal transport activity
[12–18]. Interestingly, some ALS-causing SOD1 mutant proteins can
differentially affect the axonal transport of distinct cargos. While fast
transport of vesicleswas observed to be suppressed in both anterograde
and retrograde directions in ALS mice [19], transport of cytoskeletal
elements including neuroﬁlaments was reported to be slowed only in
the anterograde direction [17,20].Moreover, different studies show that
mitochondrial movement could be suppressed in anterograde [19] and
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several familial ALS-linked SOD1 mutants colocalize with the dynein–
dynactin complex in cultured cells and affected tissues of ALS mice
[15,22].We also showed thatmutant SOD1 interactedwith the dynein–
dynactin complex and that this interaction contributed to the formation
of large SOD1 inclusions [22,23].
While the dynein–dynactin complex is the only retrograde
transport motor, a total of 45 kinesin superfamily (KIF) genes have
been identiﬁed in themouse and human genomes, and of these, 38 are
expressed in the brain. The KIF genes are classiﬁed into 14 families
(kinesin 1–14) based on phylogenetic analysis [24]. A recent study
showed that mutant SOD1 could interact with KAP3 (kinesin-
associated protein 3), a subunit of kinesin-2 complexes. Furthermore,
the sequestering of KAP3 by mutant SOD1 was suggested to cause
reduced transport of ChAT (a known KAP3-kinesin-2 cargo) in an ALS
model [25]. A large genome-wide analysis of single nucleotide
polymorphisms (SNPs) in a set of 1821 sporadic ALS cases and 2258
controls revealed that a variant within the KAP3 gene was associated
with decreased KAP3 expression and increased survival in sporadic
ALS [26]. These new ﬁndings provide an emerging concept that axonal
transport might be involved in both familial and sporadic ALS.
The aim of this study was to investigate whether mutant SOD1s can
also interact with and affect the transport mediated by three closely
related members (KIF5A, KIF5B, and KIF5C) of the kinesin-1 family.
KIF5A and KIF5C are neuron-speciﬁc and play essential roles in axonal
transport, while KIF5B is also expressed in non-neuronal cells [24]. The
KIF5 subtypes can form homo- or heterotetramers and about half of the
KIF5s are believed to form tetrameric complexes by recruiting two
kinesin light chain (KLC)molecules. The KIF5motor proteins have been
suggested to transport many cargos important for neurons including
neuroﬁlaments, mitochondria, and SNARE proteins essential for
synaptic vesicle docking [24]. In Drosophila, mutations in the KIF5
homologue KHC inhibited neuronal sodium channel activity, action
potentials, and neurotransmitter secretion [27,28]. Furthermore, these
Drosophila mutants also developed a motor neuron disease phenotype
due to the disruption of fast axonal transport [29]. In mice, inhibition of
KIF5B dramatically changed the distribution of mitochondria towards
the cell center in neurons including motor neurons [30].
In this study, we compared the ability of mutant SOD1 to interact
with and affect KIF5 transport with the interaction and effect on the
retrogrademotor complex dynein–dynactin. Using coprecipitations, we
showed that, unlike with dynein–dynactin, there is no detectable
interaction between mutant SOD1s and KIF5s. Immunostaining experi-
ments also showed no change in the expression pattern or sequestering
of KIF5 into mutant SOD1 inclusions in G93A ALS mice. Furthermore,
sciatic nerve ligation experiments performed on 60-day-old presymp-
tomatic G93A SOD1 ALS transgenic mice revealed reduced retrograde
transport of dynein. In contrast, no decrease in anterograde transport as
indicated by KIF5 accumulation could be observed in G93A mice.
Interestingly, the slowing of anterograde transport of dynein heavy
chain as a cargowas observed in the presymptomatic G93Amice. Based
on the results from this study, we suggest that disruption of dynein-
mediated transport is an early event in G93A mice starting before
disease onset and could contribute to the neuronal death in ALS.
Concerning anterograde transport, mutant SOD1 might only interact
with and interfere with some kinesin members, which, in turn, could
result in the impairment of a selective subset of cargos.
2. Materials and methods
2.1. Plasmid construction
Mouse kinesin light chain 2 (KLC2) gene was ampliﬁed from the
pcDNA3-rKLC2 construct (a generous gift from Dr. Xiaojiang Li at Emory
University) by PCR using two primers with the sequence 5′-
GACTGCGGCCGCTATGGCCACGATGGTGCTTC-3 ′ and 5 ′ -GACTGCGGCCGCTTAGCCCACGAGGGAGCTT-3′. The ampliﬁed DNA frag-
ment was inserted into the pEBG vector that can express glutathione S-
transferase (GST) fusion proteins in mammalian cells [22]. The SOD1–
FLAG and SOD1–GFP constructs were described in a previous study [22].
The ﬁdelity of all the constructs was conﬁrmed by DNA sequencing.
2.2. GST pull-down and immunoprecipitation of DHC and KIF5
HEK293 cells transfected with both SOD1–FLAG and KLC2–GST
constructs were harvested and lysed in 1 ml of RIPA buffer. The
protein concentration was determined by Bradford assay (BioRad).
Four hundred micrograms of lysate were incubated with 40 μl of 50%
slurry of glutathione Sepharose beads (GE Healthcare) in a total
volume of 1 ml for 3 h at 4 °C to allow isolation of the GST fusion
proteins. The GST beads were then collected, washed, and boiled in
2×SDS sample loading buffer. The proteins released from the beads
were subjected to 10% SDS–PAGE followed by Western blotting. The
reciprocal FLAG immunoprecipitation was performed using anti-FLAG
M2 beads (Sigma).
KIF5 immunoprecipitationswere carried out for the dissectedmice
spinal cords and sciatic nerves using a mouse monoclonal antibody
(MAB1614, Chemicon) and protein G-Sepharose (GE Healthcare). The
immunoprecipitated proteins were subjected to 10% SDS–PAGE
followed byWestern blotting. Antibodies used in theWestern blotting
are rabbit anti-SOD1 (sc-11407; Santa Cruz), mouse anti-KIF5, mouse
anti-KLC (MAB1617; Chemicon), and mouse anti-Myc (sc-40; Santa
Cruz). Intensities of Western blotting bands were quantiﬁed using the
Kodak 1D software (version 3.6.1).
2.3. Animals
Transgenic mice strains overexpressing WT and G93A mutant
SOD1 were generously provided by Dr. Zuoshang Xu (University of
Massachusetts Medical School). The mice were generated from B6.Cg-
Tg(SOD1)2Gur/J and B6.Cg-Tg(SOD1-G93A)1Gur/J stains [31] and
bred and maintained as hemizygotes at the University of Kentucky
animal facility. Transgenicmicewere identiﬁed using PCR. G93A SOD1
transgenic mice were sacriﬁced at ages of 35, 60, 90, and 125±5 days.
Age-matched WT SOD1 transgenic mice were sacriﬁced as controls.
Mice were anesthetized with an intraperitoneal injection of 0.1 ml of
pentobarbital (50 mg/ml, Abbott Laboratories) and transcardically
perfused with 0.1 M phosphate-buffered saline (PBS), pH 7.5, before
spinal cords, and other tissues were dissected. All animal procedures
were approved by the university IACUC committee.
2.4. Mice sciatic nerve ligation
Mice 60±5 days old (presymptomatic as they were clean of any
observable clinical signs) were anesthetized with an intraperitoneal
injection of 100 mg/kg ketamine and 10 mg/kg xylazine. All surgical
instruments were sterilized before surgery and then washed and heat-
treated. Sciatic nerves on both hind limbs were exposed, the left nerve
was ligated, and the right nerve was used as sham control. Silk sutures,
7-0, were used to ligate the left nerve at midthigh level. To ensure
complete block of transport, two ligationswere done 1–2 mmapart. On
the sham control side, a small piece of suture was left untied under the
nerve. After checking hemostasis, the muscle and the adjacent fascia
were closedwith sutures, and the skinwas closedwith clips. After 24 or
48 hours, the mice were sacriﬁced by CO2 asphyxiation and both sciatic
nerves were dissected, ﬁxed, cryoembedded, and sectioned.
Kinesin and dynein motor proteins were characterized using
immunoﬂuorescence. KIF5A, and dynein heavy chain antibodies were
used for motor protein accumulation detection. For quantiﬁcations, the
average signal intensity for a size-deﬁned area (0.0625 mm2) just
adjacent to the ligation site on the proximal (P1) or the distal side (D1)
was divided by the average signal intensity from a similar sized control
Fig. 1. Mutant SOD1 interacts with dynein–dynactin but not with KIF5–KLC2 in HEK293
cells. (A). HEK293 cells were cotransfected with GST–KLC2 or GST–DIC and SOD1–FLAG
(WT, A4V, G85R, and G93A). GST pull-down analysis revealed that KIF5 was pulled-down
with KLC2-GST, but none of the A4V, G85R, or G93A SOD1mutant was pulled down with
the kinesin complex. In contrast, all SOD1 mutants were pulled down with the dynein
complex in GST–DIC pull-downs. Blotting for the dynactin p150Glued subunit showed that
the dynactin complex was also coprecipitated with dynein. (B). Reverse FLAG IPs showed
that neither GST–KLC2 nor KIF5 was coprecipitated with WT or mutant SOD1. However,
GST–DIC was coprecipitated with mutant SOD1 but not with WT SOD1.
709P. Shi et al. / Biochimica et Biophysica Acta 1802 (2010) 707–716area on the proximal (P2) or distal side (D2). Longitudinal sections from
ligated and shamnerves from4 to 6G93Aand from4 to 6WTmicewere
analyzed at each time point. Two-way analysis of variance (ANOVA)
followed by Tukey's testwasperformed since our studyhad two factors:
factor A (WT versus G93A mice) and factor B (proximal versus distal
sites).
2.5. Fluorescence microscopy
Immunohistological analyses were performed on lumbar spinal
cords and sciatic nerves of ALS animals at various ages as indicated.
Spinal cords were dissected, postﬁxed overnight in 4% paraformalde-
hyde in 0.1 M PBS, dehydrated, and embedded in Paraplast X-tra
(Tyco Healthcare). Sections (6 μm) were deparafﬁnized, rehydrated,
and boiled in 0.01 M citrate buffer (pH 6.0) for 15 min to retrieve
antigens. Sciatic nerves were postﬁxed for 2 h in 4% paraformalde-
hyde, cryopreserved in 30% sucrose overnight, embedded in tissue-
Tek OCT compound [25], and 10-μm sections were cut.
Parafﬁn and cryosections were blocked in 10% heat-inactivated fetal
bovine serum in 0.1 M PBS with 0.1% Triton X-100 (PBST) for 30 min
before being incubatedwith primary antibodies diluted in 1% fetal bovine
serum–PBST overnight at room temperature. The sheep SOD1 antibody
(PC077; The Binding Site), rabbit KIF5A antibody (K0889; Sigma), and
rabbit DHCantibody (sc-9115; Santa Cruz)wereused at 1:400, 1:400, and
1:200, respectively. Followingprimary antibody incubation, sectionswere
washed with PBST and incubated with 4′,6-diamidino-2-phenylindole
dihydrochoride (DAPI; Sigma) at 1:7500 and incubated with Alexa Fluor
488 anti-sheep (Molecular Probes) at 1:250. Sections were then washed
with PBST, incubatedwith Alexa Fluor 594 anti-rabbit (Molecular Probes)
at 1:300, and then mounted using Vectashield mounting medium.
Fluorescence microscopy was carried out using a Leica DM IRBE laser
scanning confocal microscope with a 100× objective.
3. Results
3.1. No or very weak interaction between KIF5–KLC2 complexes and
wild-type or mutant SOD1 in cultured cells
Decreased axonal transport has been observed in ALS. It has been
demonstrated recently that ALS-related mutant SOD1 proteins can
interact with both the anterograde motor protein kinesin-2 complex
via KAP3 [25] and the retrograde motor protein complex dynein–
dynactin [22]. To investigate whether mutant SOD1s can also directly
or via a kinesin light chain (KLC) interact with three members of the
kinesin-1 family (KIF5A, B, or C), the plasmid encoding GST-tagged
kinesin light chain 2 (GST–KLC2) was cotransfected with SOD1–FLAG
constructs into HEK293 cells. Forty-eight hours after the transfection,
cell extracts were prepared and GST pull-down was performed to
precipitate GST–KLC2. As shown in Fig. 1A, blotting with an antibody
recognizing all three subtypes of KIF5, we showed that KIF5s were
coprecipitated with KLC2 (lanes 1–4 of the top panel). The result was
consistent with previous studies showing that KLC2 and KIF5s form
kinesin complexes. However, no detectable wild-type (WT) ormutant
SOD1-FLAG could be observed in the GST–KLC2 pull-down (lanes 1–4
of the top panel). In contrast, Western blotting of cell extracts showed
that GST–KLC2 and SOD1–FLAG were expressed in all samples
(Fig. 1A). These results suggest that, while KIF5–KLC2 complex was
pulled-down by GST-KLC2, no signiﬁcant amount of WT or mutant
SOD1 was coprecipitated with the kinesin-1 complexes.
In comparison, the mutant SOD1 proteins (A4V, G85R, and G93A)
were readily coprecipitated with the dynein–dynactin complex in
GST–DIC (dynein intermediate chain) pull-downs (lanes 7–9),
whereas WT SOD1 was not (lane 6). A dynactin subunit p150 was
visualized to show coprecipitation of dynactinwith GST–DIC (lanes 6–
9 in the middle panel). The GST control vector was cotransfected with
A4V (lane 5) and G93A SOD1 (lane 10) as negative controls.The reciprocal FLAG immunoprecipitation was performed to verify
the above results. As shown in Fig. 1B, no or very little GST–KLC2 could
be detected in either WT or mutant SOD1 immunoprecipitations.
Western blotting of cell extracts again showed that expression levels
of GST–KLC2 (lanes 1–5) and SOD1–FLAG (lanes 1–4 and 6–9) were
comparable in all samples. The data again suggest that there is no
speciﬁc interaction between SOD1 and the KLC2-containing kinesin-1
complexes (lanes 1–4). For comparison, GST–DIC was coprecipitated
with A4V, G85R, and G93Amutants (lanes 7–9) but not withWT SOD1
(lane 6) or FLAG control (lane 10). The results concerning the
interaction between mutant SOD1 and the dynein complex in both
Figs. 1A and B are consistent with our previously published data [22].
3.2. No or very weak interaction between KIF5 and wild-type or G93A
SOD1 in transgenic mice
We further testedwhether SOD1 could interactwith KIF5s in theWT
and G93A SOD1 transgenic mice. Spinal cord homogenates from 125-
day-old WT or G93A SOD1 transgenic mice were subjected to
immunoprecipitation using an antibody that can recognize all three
KIF5 subtypes (KIF5; Figs. 2A and B). For comparisons, coprecipitations
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using a DIC antibody (Fig. 2C). Consistent with the previously published
data [22], G93Amutant SOD1was coprecipitatedwith DIC, whereasWT
SOD1 was not (Fig. 2C). However, although we could immunoprecip-
itate KIF5 (Fig. 2A, lanes 2 and 3) and kinesin light chains KLC1 andKLC2
(Fig. 2A, middle panel) using the KIF5 antibody, neither WT nor G93A
SOD1was coprecipitatedwith the KIF5s (Fig. 2A, lower panel).Western
blotting of the spinal cord extracts showed that WT and G93A SOD1,
KIF5, KLC1, and KLC2 were all expressed (lanes 4 and 5). Furthermore,
the immunoprecipitation experimentwas also performedwith 35-, 60-,
and 90-day-old mice. As shown in Fig. 2B, neither WT nor G93A SOD1Fig. 2. No detectable interaction between SOD1 and KIF5 motor proteins in G93A ALS
mice. (A). All three KIF5 subtypes were immunoprecipitated from spinal cord protein
extracts of 125-day-old WT and G93A mice using an anti-KIF5 antibody and protein G
Sepharose. Western blotting of IP samples showed that kinesin light chains KLC1 and
KLC2 known to form complexes with KIF5s were also pulled down together with the
KIF5s. However, neither WT nor G93A SOD1 was coprecipitated with KIF5. (B). KIF5 IPs
were performed as described above from spinal cord of ALS mice of different ages (35,
60, 90, and 125 days old). Again, neither WT nor G93A SOD1 could be detected in KIF5
IPs. Input control showed that WT and mutant SOD1 was expressed in all samples. (C).
DIC immunoprecipitation showed that mutant SOD1 was coprecipitated with the
dynein–dynactin complex while WT SOD1 showed little coprecipitation. The IgG heavy
chain and light chain of antibodies used in the IPs are noted.was coprecipitated with KIF5 in mouse samples at any time point.
Western blotting of the spinal cord extracts showed that KIF5 levels in
the protein extracts where similar in all samples. These data suggest
that, in contrast to the situation with the dynein–dynactin, there is no
detectable interaction between mutant SOD1 and KIF5 or KIF5–KLC
complexes.
3.3. No colocalization between KIF5A and SOD1 inclusions in G93A
transgenic mice
We next tested whether any colocalization of SOD1 and KIF5A
could be observed in the WT and G93A SOD1 transgenic mice. Spinal
cord and sciatic nerve sections from 60-, 90-, and 125-day-oldWT and
G93A SOD1 transgenic mice were coimmunostained with SOD1 and
KIF5A antibodies to visualize possible colocalization in neurons
(Figs. 3A and B). No indication of sequestering of KIF5A into mutant
SOD1 inclusions was observed in either spinal cord motor neurons or
the sciatic nerve axons in SOD1 transgenic mice at any time point. The
coimmunostaining data are consistent with our in vitro and in vivo
coprecipitation results, suggesting that KIF5A and KIF5A–KLC com-
plexes have no or little interaction with mutant SOD1. The data are
also consistent with the ﬁndings in a recent study also showing no
colocalization of mutant SOD1 and kinesin [32]. The results suggest
that KIF5A is different from the kinesin-2 subunit KAP3 [25] or various
dynein–dynactin subunits [15,22] that have been reported to
colocalize with mutant SOD1 inclusions.
In addition, the stainings of the neuronal speciﬁc KIF5A revealed a
punctuated pattern in anterior hornmotor neurons, consistent with the
role of KIF5A in trafﬁcking. Moreover, the KIF5A levels appeared similar
in the remaining motor neurons in G93A mice to those found in motor
neurons of age-matched WT SOD1 transgenic mice (Fig. 3). The results
are consistent with the Western blot results in Fig. 2, suggesting that
KIF5A levels remained largely unchanged in motor neurons.
3.4. Suppression of dynein–dynactin retrograde transport but not KIF5A
anterograde transport in presymptomatic G93A mice
To examine the effect of mutant SOD1 on bidirectional axonal
transport in neurons of G93A mice, sciatic nerve double ligation surgery
and subsequent immunostaining were performed. The presymptomatic
60-day-old G93A mice were used to investigate early effects on axonal
transport and to prevent axonal loss in the G93A mice from interfering
with the analysis. The age-matched WT SOD1 transgenic mice were
included for comparison. Molecules transported in the anterograde
direction will accumulate on the proximal side of the ligation while
retrogrademoleculeswill accumulate on thedistal side of the ligation (see
scheme in Fig. 6A). Accumulation of kinesin and dynein motor proteins
was hence used as a surrogate measurement of anterograde and
retrograde axonal transport, respectively. The mice were euthanized 24
or 48 hours after ligations, the sciatic nerves from both sides (one ligated
and one sham) were dissected, sectioned and stained with antibodies
against neuroﬁlament-M and the dynein heavy chain (DHC) or neuronal
KIF5A. Figs. 4 and 5 show the representative images of DHC and KIF5A
immunostaining in the sciatic nerve sections, respectively. The quantiﬁca-
tions of dynein and kinesin accumulation are shown in Figs. 6B and C. The
intensity of dynein or kinesin immunoﬂuorescence close to the ligation on
the proximal side (area P1) or the distal side (areaD1)was normalized by
division of the background intensity of kinesin or dynein measured at
proximal or distal control areas (P2 or D2) in the same section (see
Fig. 6A). The accumulation of DHC and KIF5A is presented as the
normalized intensity, i.e., the ratios of P1/P2 or D1/D2 in both G93A and
WT mice. Statistical analysis was performed using two-way ANOVA
followed by Tukey's test.
Analysis of dynein staining revealed that, compared to the sham
nerve control, increased dynein staining could be observed on the distal
side of the ligation after 24 and 48 hours in both WT and G93A mice
Fig. 3. KIF5A does not colocalize with mutant SOD1 in inclusions. (A). KIF5A and SOD1 localization was investigated using coimmunoﬂuorescence staining of lumbar spinal cord from
60-, 90-, and 125-day-old G93A mice and age-matched controls. A decrease in the total number of surviving motor neurons could be observed in end-stage (125 days old) G93A
mice. KIF5A staining revealed robust KIF5A expression in surviving motor neurons and no sign of co-localization of KIF5A with mutant SOD1 aggregates. (B). KIF5A and SOD1
stainings of sciatic nerve sections from 60- and 90-day-old G93A mice. No colocalization of KIF5A and mutant SOD1 aggregates could be observed. The scale bars are 20 µm.
711P. Shi et al. / Biochimica et Biophysica Acta 1802 (2010) 707–716
Fig. 4. Representative immunostaining of dynein after sciatic nerve ligation. The left sciatic nerve was exposed and ligated whereas the right nerve was a sham control. At 24 (A) or
48 hours (B) after the ligation surgery, the mice were euthanized, and the nerve was collected, sectioned, and stained for dynein using an anti-dynein heavy chain antibody. The
nerve was also stained with a neuroﬁlament-M antibody. Dynein stainings revealed accumulation of dynein on both proximal and distal sides of the ligation inWT and G93Amice in
the ligated, but not the sham nerve. Compared to WT, reduced accumulation was observed in G93A mice 24 hours after ligation (A). No apparent difference in dynein accumulation
between WT and G93A mice was observed 48 hours after ligation (B).
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Fig. 5. Immunostainings of KIF5A after sciatic nerve ligations. Nerves were ligated and prepared as in Fig. 4 and then stained with a KIF5A speciﬁc antibody and a neuroﬁlament-M
antibody. KIF5A showed mostly proximal accumulation after ligation for 24 (A) or 48 hours (B). No visible difference between WT and G93A could be observed in either panel.
Fig. 6. Quantiﬁcation of dynein and KIF5A staining after sciatic nerve ligation showed decreased dynein retrograde transport, but no decrease in KIF5A anterograde transport. (A).
Schematicdrawing of thequantiﬁcation setup. The average signal intensity for a sizedeﬁned area (0.0625 mm2) just adjacent to the ligation site on the proximal (P1) or the distal side (D1)
wasnormalized against the average signal intensity froma similar sizedcontrol areaon theproximal (P2) ordistal side (D2). Longitudinal sections from ligated and shamnerves from4 to6
G93A and from 4 to 6WT mice were analyzed at each time point. Quantiﬁcations of dynein (B) and KIF5A (C) stainings at the proximal and distal sides of the ligation site. Statistics was
performed using two-way ANOVA followed by Tukey's test. A statistically signiﬁcant proximal and distal accumulation of dynein in bothWT and G93Amicewas observed 24 hours after
ligationwhencompared to the shamcontrol nerve.However, both theproximal anddistal accumulationswerestatistically signiﬁcantly reduced inG93Amice compared toWTmice. Forty-
eight hours after ligation, there was no longer any difference in dynein accumulation betweenWT and G93Amice. KIF5A showed predominantly proximal accumulation in bothWT and
G93A mice and no statistically signiﬁcant difference could be observed between WT and G93A mice at any time point. *p≤0.05, **p≤0.005.
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accumulation of dynein inG93Amicewas signiﬁcantly less compared to
the accumulation in WT mice (p=0.031). However, after 48 hours,
there was no statistically signiﬁcant difference in the distal accumula-
tion of dynein in WT and G93A mice (p = 0.820). These results
suggested that retrograde transport as inferred by the accumulation of
dynein motor protein was not completely blocked, but slowed down in
the presence of mutant SOD1.
Dynein also accumulated on the proximal side of the ligation
compared to sham control in both WT and G93A mice (Figs. 4A and B
and 6B). Dynein accumulation at the proximal side after nerve crush
or ligation has been previously reported by other laboratories and is
most likely due to kinesin-mediated anterograde transport of dynein
toward the synapse [20,33,34]. The proximal accumulation of dynein
at 24 hours was also decreased in G93A mice compared to WT mice
(p=0.013). This suggests that the anterograde transport of dynein
could be impaired in G93A mice.
KIF5A immunostaining showed stronger accumulation on the
proximal ligation side than the distal side in both WT and G93A (Figs. 5
and 6C). Furthermore, no decreased accumulation of KIF5A could be
observed in G93A mice compared to control mice. Instead, although not
statistically signiﬁcant a trend toward a slight increase in KIF5A proximal
accumulation could be observed in G93A at both 24 and 48 hours.
Taken together, these data show that reduced axonal transport
could be observed in both anterograde and retrograde directions at an
early presymptomatic stage of the ALS mice using the immunostain-
ing intensity of DHC as a marker at the proximal and distal sides of the
ligation sites. In comparison, using KIF5A as a marker, we could not
observe any change in KIF5A-mediated anterograde transport in G93A
mice at this presymptomatic stage.
4. Discussion
We have previously shown that several ALS mutants of SOD1 can
interact with the dynein–dynactin complex, which is responsible for
retrograde axonal transport [22]. We have also demonstrated that the
interaction between mutant SOD1 and dynein–dynactin plays a
functional role in the formation of mutant SOD1 inclusions [23]. In
this study, we used the sciatic nerve double ligation technique, which
has long been used to evaluate the rate of bidirectional transport under
physiological and pathological conditions [35–37], to determine
whether the bidirectional axonal transport was impaired. In addition,
we investigated whether mutant SOD1 could interact with and disrupt
the anterograde axonal transport mediated by the kinesin-1 family
members. Kinesin-1 proteins are abundant in neurons and have been
shown to transport several cargos vital for neuronal function and
survival. The goals of the study were to compare the interaction of
mutant SOD1with dynein–dynactin and the kinesin-1 family members
and to compare the effect of mutant SOD1 on the corresponding
retrograde and anterograde axonal transport.
The interaction between mutant SOD1 and dynein-dynactin was
again demonstrated in cultured cells and ALSmouse spinal cords in this
study. Based on the quantiﬁcation of motor protein DHC accumulation
at the distal side of the sciatic nerve ligation site 24 hours after ligation,
we showed that the dynein-mediated axonal transportwas signiﬁcantly
suppressed in 60-day-old presymptomatic G93Amice compared toWT
SOD1 mice (Figs. 4 and 6B). Interestingly, the data from the 48-hour
postligation samples showed no difference in dynein accumulation
betweenG93A andWT SOD1mice, suggesting that retrograde transport
is not completely blocked but rather slowed down. These data, together
with our previous studies [22,23], support the hypothesis that there is
an early impairment of axonal retrograde transport in the G93A SOD1
transgenic mice, presumably due to the interaction between mutant
SOD1 and dynein–dynactin. This hypothesis is further supported by
other studies that mutant SOD1 could alter the subcellular localization
of dynein–dynactin [15]. The same study also showed a decrease ofretrograde transport in 50-day-old G93A mice using a neurotracer
approach.
The reduced retrograde transport could contribute to the motor
neuron death by decreasing the removal of damaged mitochondria
from the synapse or by reducing the level of survival signals induced
by neurotrophic factors secreted by the muscle [38]. Since dynein–
dynactin is the only major motor protein responsible for retrograde
transport, the alterations in the retrogradely transported cargos may
be an alternative mechanism contributing to motor neuron death. In
fact, a recent study reported a switch in retrograde signaling from
prosurvival to stress in ALS mice [37].
Besides its role in retrograde axonal transport, the dynein–dynactin
complex also have many other functions, including participation in
mitosis, endoplasmic reticulum to Golgi vesicular trafﬁcking, neuronal
migration, neurite outgrowth, synapse formation, formation of aggre-
somes, and protein degradation by autophagy (for review, see Strom et
al. [39]). The interaction between mutant SOD1 and dynein–dynactin
could hence have various consequences. In two other recent studies
from our laboratory, we found that the amount of mutant SOD1
interacting with dynein–dynactin increases with disease progression
and that this interaction between mutant SOD1 and dynein–dynactin
plays a role in formation of large aggresome-like SOD1 inclusions
[22,23]. Increasing levels of dynein–dynactin interacting with mutant
SOD1 and sequestration of dynein into aggresome-like inclusions could
also lead to depletion of the pool of dynein available for axonal
transport. Since dynein is also important for autophagic degradation of
protein aggregates [40], disruption of dynein function might also slow
down the autophagic degradation of misfolded SOD1. This would
further increase the cellular load of mutant SOD1 and the subsequent
sequestration of dynein–dynactin.
In contrast to the interaction with and reduction of dynein–dynactin
retrograde transport, we could not ﬁnd any evidence for an interaction
betweenmutant SOD1 and themembers of the kinesin-1 family (KIF5A,
5B, or 5C) in cell culture or in mice spinal cords (Figs. 1 and 2).
Immunostaining of the neuron-speciﬁc KIF5A in both spinal cords and
sciatic nerves of transgenic ALSmice failed to reveal any colocalization of
KIF5A and mutant SOD1 aggregates in motor neurons (Fig. 3).
Furthermore, we could see no decrease in KIF5A-mediated anterograde
transport in 60-day-old G93A mice using KIF5A accumulation as a
surrogate measurement. This was unexpected since reduced antero-
grade transport has previously been shown tobe an early event inALS. In
fact, a study using an antibody recognizing all three KIF5 subtypes
showed reduced proximal accumulation of KIF5 after sciatic nerve
ligations in presymptomatic low copy version of G93A [20]. This
difference could be due to usage of the different G93A lines or different
antibodies recognizing all KIF5 subtypes versus the antibody speciﬁc for
neuronal KIF5A used in our study. Perlson et al. recently showed that
both retrograde and anterograde transports were suppressed in 85-day-
old G93A mice by measuring accumulation of DIC and kinesin heavy
chain at the sciatic nerve ligation sites [37]. The age of mice used in this
studywas60 days, younger than those used in [37]. It is possible that the
anterograde transport is not altered in 60-day-old mice, while
impairment of transport becomes detectable in 85-day-old mice that
are at the verge of developing clinical symptoms. In addition, the
antibodies used in the two studiesweredifferent, particularly thekinesin
antibodies.Weused anantibody speciﬁc for neuronal isoformKIF5A. It is
possible that the anterograde transport mediated by KIF5A motor
protein is not changed in G93A mice, while the transport mediated by
other kinesin family members is changed.
A recent study showed that misfolded SOD1 interacted with the
kinesin-2 motor complex via the KAP3 subunit. Furthermore, seques-
tering of KAP3 by mutant SOD1 was suggested to result in inhibition of
ChAT transport [25]. In addition, a genome-wide SNP analysis in a large
set of sporadic ALS cases in U.S. and Europe revealed that a variant
within the KAP3 gene was associated with decreased KAP3 expression
and increased survival in sporadic ALS [26]. The above two independent
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both familial and sporadic ALS.
Interestingly, we observed a decrease in proximal dynein accumu-
lation 24 hours after sciatic nerve ligation inG93Amice compared to the
WT mice (Figs. 4 and 6B). Accumulation of dynein at the proximal side
has also previously been shown and is most likely due to kinesin-
mediated anterograde transport of dynein as a cargo toward the synapse
[20,33,34]. Thus, our data suggest that dynein might be a cargo whose
anterograde transport is affected by mutant SOD1 in ALS. Using live
imaging of primary DRG neurons isolated from ALS mice, De Vos et al.
[19] examined axonal transport of other cargos and showed that
transport of membrane bound organelles was affected in both
anterograde and retrograde directions, whereas transport of mitochon-
dria was only affected in the anterograde direction. A separate study,
however, showed that axonal transport of mitochondria in differenti-
ated NSC34 cells was affected in both anterograde and retrograde
directions in the presence of mutant SOD1 [21,41]. The speciﬁc kinesin
motor protein(s) transporting these cargos, which showed reduced
transport, was not investigated in those studies. Furthermore, the
mechanism(s) underlying the decreased anterograde transport by
mutant SOD1 is also unclear. It is possible that the reduced transport
of these cargos could depend on reduced binding of these cargos to the
motors rather than decreasedmotor transport/activity. In fact, reduced
cargo binding have been suggested in ALS disease (for review, see De
Vos et al. [42]). Studies have suggested that pathogenic proteins
implicated in various neurodegenerative diseases can alter kinase
signaling cascades and cause disruption in kinesin-mediated fast axonal
transport [43–45]. A hypothesis suggesting changes in the p38 signaling
in the presence of mutant SOD1 has also been proposed [18].
In our study looking directly at the KIF5A kinesin motor transport,
we could not see decrease in anterograde movement of the motor
itself. However, there could still be reduced transport of certain KIF5A
cargos if cargo attachments where problematic. The observation of the
impaired anterograde transport of DHC as a cargo provides an
example for such disruptive events. Taken together, the results of
this study and previous studies suggest that mutant SOD1 might only
interact with and interfere with speciﬁc kinesin members, which, in
turn, could result in the impairment of a selective subset of cargos.
Thus, it is critically important to examine the effect of mutant SOD1 on
speciﬁc kinesin subtypes as well as different cargos using both in vitro
live cell imaging and in vivo approaches to further our understanding
of axonal transport defects in ALS disease.
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